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Items for this week’s EPI Update include: 
  
• Yellow fever vaccine shortage  
• Morgellons study  
•        Nationwide recall of pre-filled heparin and normal saline flushes  
• Meeting announcements and training opportunities  
  
Yellow fever vaccine shortage 
For months, yellow fever vaccine providers across Iowa have reported a 
shortage of the yellow fever vaccine (VF-FAX) single-dose vials. According to the 
manufacturer, Sanofi Pasteur, there is no shortage of the vaccine itself, but there 
is a temporary issue related to the production equipment use to insert the 
vaccine into single-dose vials. Delays occurred when the supplier of this 
equipment went out of business, making it necessary to validate a new supplier. 
The 5-dose vials of YF-VAX continue to be available in sufficient supply but 
requires reconsituted vaccine to be used within 60 minutes. The single-dose vials 
are expected to be back in stock in March 2008.  Until that time, yellow fever 
clinics are encouraged to batch vaccination times where they schedule five 
people to come in for yellow fever vaccination within an hour, so they can 
maximize the 5-dose vial's use.  
  
Health-care providers should refer to Chapter 5: Yellow Fever Vaccine 
Requirements and Information on Malaria Risk and Prophylaxis by Country in 
CDC Health Information for International Travel 2008, for information about which 
countries require yellow fever vaccination for entry and for which countries CDC 
recommends yellow fever vaccination. In the absence of a country requirement, 
CDC does not recommend yellow fever vaccination for travel to a country if the 
traveler's itinerary does not include travel to a yellow fever-endemic area. 
Traveler’s should receive the vaccine 10 days prior to travel.  Due to the 
shortage, Iowa travelers are encouraged to schedule vaccination appointments 
early.   
  
To access the Travelers' Health announcement, go to  
www.cdc.gov/travel/contentYellowFeverVaccineShortage.aspx. 
To find out which countries require yellow fever vaccine, go to 
www.cdc.gov/travel/yellowBookCh5-MalariaYellowFeverTable.aspx. 
  
Morgellons study 
The Centers for Disease Control and Prevention (CDC), in conjunction with 
Kaiser Permanentes Northern California Division of Research, launched a study 
to learn about an unexplained skin condition known as Morgellons. Case patients 
report a range of symptoms including non-healing skin lesions, emergence of 
fibers or solid material from the skin, abnormal skin sensations (such as stinging 
and biting or pins and needles) and non-cutaneous symptoms such as difficulty 
concentrating and short-term memory loss. 
  
The cause of  Morgellons is unknown; the medical community has insufficient 
information to determine whether case patients have a common cause for their 
symptoms or share common risk factors. Researchers hope to learn more about 
factors that may contribute to illness.   
  
Nationwide recall of pre-filled heparin and normal saline flushes  
There is a nationwide recall of all lots of both heparin and saline pre-filled flushes 
manufactured by AM2 PAT. These products are distributed under two brand 
names, Sierra Pre-Filled, Inc. and B. Braun. These products are sold in 3ml, 5ml 
sizes for heparin and 3ml, 5ml and 10ml sizes for normal saline. Both products 
are sold as pre-filled syringes.  
  
Lot 1003-02 and lot 070926H heparin IV flush syringes have been found to be 
contaminated with Serratia marcescens, which has resulted in patient infections. 
CDC has confirmed growth of Serratia marcescens from several unopened 
syringes of this product. This bacterial infection could present a serious adverse 
health consequence that could lead to life-threatening injuries and/or death. 
  
Iowa consumers and facilities that have any of these recalled pre-filled syringes, 
Heparin or Saline Lock Flush Solution USP, should stop using the product 
immediately. These products should be returned to your distributor immediately.  
  
For more information, visit www.fda.gov/oc/po/firmrecalls/am2pat01_08.html. 
  
Meeting announcements and training opportunities 
  
“Norovirus School Prevention and Management”  
            Iowa Communications Network, January 28, 2:00 – 3:00 p.m. 
Public health personnel are asked to help promote this ICN to our 
colleagues in the school setting. This ICN from K-12 Connections will 
discuss school-related prevention of norovirus outbreaks.  
For more information, visit www.iptv.org/iowa_database/event-
detail.cfm?ID=8503. 
  
  
Have a healthy and happy week! 
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